This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Cramer's 'Mad Money Lightning Round': Ode to Omniture

To see the full "Mad Money" Recap, please click here .

Here's what Jim Cramer had to say about some of the stocks that callers offered up during the "Mad Money Lightning Round" Friday evening:

Onyx Pharmaceuticals (ONXX): "They've got the only drug for liver cancer. I reiterate my buy. ... I want to be in it."

Spartan Stores (SPTN): "52-week high." Cramer said he'd swap out of it and move into Kroger (KR - Get Report), which is "much cheaper."

Netease (NTES): "No Netease." Cramer said he'd be in (BIDU) instead.

Given Imaging (GIVN): "I like Given very much. I think it's a great speculative stock."

Bentley Pharmaceuticals (BNT): "I think the generic industry is really awful. I don't want to touch it."

Great Lakes Dredge & Dock Corporation (GLDD - Get Report): "It was a trade going into the Russell, and then you had to move on. ... I don't look back at trades."

Omniture (OMTR): "I've been behind Omniture since they went public. ... I would certainly buy it at $22. I do not believe that Omniture will be public at this time next year."
1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
ONXX $0.00 0.00%
GIVN $0.00 0.00%
GLDD $4.52 0.67%
KR $34.92 -0.24%
SIX $58.05 -0.70%


Chart of I:DJI
DOW 17,660.71 +9.45 0.05%
S&P 500 2,050.63 -0.49 -0.02%
NASDAQ 4,717.0940 -8.5450 -0.18%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs